Carregant...
Regulating medicines in Europe: the European Medicines Agency, marketing authorisation, transparency and pharmacovigilance
Following a review process lasting almost four years, and culminating in several pieces of new European legislation, adjustments have been made to the European Union's (EU) regulatory framework for pharmaceuticals. The European Commission laid out its priorities for the review as: simplifying t...
Guardat en:
| Publicat a: | Clin Med (Lond) |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Royal College of Physicians
2006
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4954442/ https://ncbi.nlm.nih.gov/pubmed/16521363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmedicine.6-1-87 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|